Suggested Topics within your search.
Suggested Topics within your search.
- methods 5
- Therapeutic use 4
- therapeutic use 4
- Anesthesia 3
- Anesthetics 3
- therapy 3
- Anesthesiology 2
- Biochemistry 2
- Chemistry, Clinical 2
- Chemotherapy 2
- Cognitive Therapy 2
- Health and Fitness 2
- Pharmacology 2
- pharmacology 2
- Analgesia 1
- Analgesics 1
- Anti-Infective Agents 1
- Anti-infective agents 1
- Anxiety Disorders 1
- Child welfare 1
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Cognitive therapy 1
- Communicable diseases in children 1
- Congresses 1
- Cultural Diversity 1
- Custody of children 1
- Diarrhea, Infantile 1
- Diet therapy 1
- Diet therapy for infants 1
-
2621
-
2622
Microglia and Spinal Cord Synaptic Plasticity in Persistent Pain
Published 2013-01-01“…Insights into microglial-neuronal interactions in the spinal cord dorsal horn will not only further our understanding of neural plasticity but may also lead to novel therapeutics for chronic pain management.…”
Get full text
Article -
2623
Recipe for Success: Suggestions and Recommendations for the Isolation and Characterisation of Bacteriocins
Published 2021-01-01“…Although only two peptides have been approved for use as natural preservatives foods, current research is focusing on expanding their application as potential therapeutics against clinical pathogens. Our laboratory group has been working on bacteriocins for over 25 years, and during that time, we have isolated bacteriocin-producing microorganisms from a variety of sources including human skin, human faeces, and various foods. …”
Get full text
Article -
2624
Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies
Published 2016-01-01“…Anti-drug antibodies induced by biologic therapeutics often impact drug pharmacokinetics, pharmacodynamics response, clinical efficacy, and patient safety. …”
Get full text
Article -
2625
Sulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug Discovery
Published 2017-01-01“…The applications of (1) exogenous sulfated glycans of different origins and chemical structures capable of competing with the virus attachment receptors (supposedly GAGs) and (2) GAG-degrading enzymes able to digest the virus attachment receptors on the cells may be therapeutically beneficial as anti-ZIKV. This communication attempts, therefore, to offer some guidance for the future research programs aimed to unveil the molecular mechanisms underlying the ZIKV infectivity and to develop therapeutics capable of decreasing the devastating consequences caused by ZIKV outbreak in the Americas.…”
Get full text
Article -
2626
“Dead Cells Talking”: The Silent Form of Cell Death Is Not so Quiet
Published 2012-01-01Get full text
Article -
2627
A Novel and Robust Method for Investigating Fungal Biofilm
Published 2025-01-01“…It is suitable for high-throughput drug screening and repurposing efforts, aiding in the development of new therapeutics. Our technique represents a significant advancement in Candida biofilm research, addressing the need for consistent, reproducible biofilm models. …”
Get full text
Article -
2628
Potential use of peptides mimicking CRAC/CARC domains as antivirulence therapies to inhibit RTX toxins activities
Published 2024-11-01“…In recent years, research efforts have increased to develop new therapeutics aimed at combating antibiotic-resistant bacterial infections. …”
Get full text
Article -
2629
Biomarkers of Acute Kidney Injury
Published 2011-01-01“…The problems inherent in a creatinine-based diagnosis of AKI have impeded the development of proper therapeutics in AKI and posed problems in evaluating nephrotoxicity of drugs and other chemical exposures. …”
Get full text
Article -
2630
TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling
Published 2018-01-01“…The recognition of the anti-inflammatory roles of TNIP1 and improved integrated understanding of its physical and functional association with other signaling pathway proteins may position TNIP1 as a candidate target for the design and/or testing of next-generation anti-inflammatory therapeutics.…”
Get full text
Article -
2631
Selective Phenome Growth Adapted NK Model: A Novel Landscape to Represent Aptamer Ligand Binding
Published 2017-01-01“…Aptamers are single-stranded oligonucleotides selected by evolutionary approaches from massive libraries with significant potential for specific molecular recognition in diagnostics and therapeutics. A complete empirical characterisation of an aptamer selection experiment is not feasible due to the vast complexity of aptamer selection. …”
Get full text
Article -
2632
Manipulation of Type I Interferon Signaling by HIV and AIDS-Associated Viruses
Published 2019-01-01“…Type I Interferons were first described for their profound antiviral abilities in cell culture and animal models, and later, they were translated into potent antiviral therapeutics. However, as additional studies into the function of Type I Interferons progressed, it was also seen that pathogenic viruses have coevolved to encode potent mechanisms allowing them to evade or suppress the impact of Type I Interferons on their replication. …”
Get full text
Article -
2633
Ignoring Gender-Based Immunometabolic Reprograming, a Risky Business in Immune-Based Precision Medicine
Published 2025-01-01“…Therefore, sex/gender-associated immune differences and their involvement in immune-mediated diseases and immune-based therapeutics indicate the demand for gender-based IR studies to increase the efficacy of immune-based precision medicine.…”
Get full text
Article -
2634
Extracellular vesicles, RNA sequencing, and bioinformatic analyses: Challenges, solutions, and recommendations
Published 2024-12-01“…Circulating EVs carry functional small RNAs and other molecular footprints from their cell of origin, and thus have evident applications in liquid biopsy, therapeutics, and intercellular communication. Yet, the complete transcriptomic landscape of EVs is poorly characterized due to critical limitations including variable protocols used for EV‐RNA extraction, quality control, cDNA library preparation, sequencing technologies, and bioinformatic analyses. …”
Get full text
Article -
2635
Generation of human induced pluripotent stem cell lines (iPSC) from adipose-derived mesenchymal stromal cells from two patients with systemic sclerosis
Published 2025-02-01“…These SSc-specific iPSC lines can be differentiated into endothelial cells, providing a valuable model to elucidate vascular dysfunction and develop personalized therapeutic approaches.…”
Get full text
Article -
2636
-
2637
Acetyl-CoA synthesis in the skin is a key determinant of systemic lipid homeostasis
Published 2025-02-01“…Summary: ATP-citrate lyase (ACLY) generates cytosolic acetyl-coenzyme A (acetyl-CoA) for lipid synthesis and is a promising therapeutic target in diseases with altered lipid metabolism. …”
Get full text
Article -
2638
Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults
Published 2020-09-01“…Introduction To find effective and safe treatments for COVID-19, the WHO recommended to systemically evaluate experimental therapeutics in collaborative randomised clinical trials. …”
Get full text
Article -
2639
ChromaFold predicts the 3D contact map from single-cell chromatin accessibility
Published 2024-11-01Get full text
Article -
2640